Megestrol acetate: clinical experience
- 31 March 1989
- journal article
- research article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 16 (1) , 49-63
- https://doi.org/10.1016/0305-7372(89)90004-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinomaGynecologic Oncology, 1987
- Megestrolazetat versus Medroxyprogesteronazetat in der Behandlung metastasierender MammakarzinomeOncology Research and Treatment, 1987
- Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: Relationship of response to previous treatmentEuropean Journal of Cancer and Clinical Oncology, 1986
- Megestrolazetat in verschiedenen Dosierungen bei der Behandlung des metastasierenden Mammakarzinoms — Klinische und endokrinologische UntersuchungenJournal of Molecular Medicine, 1985
- Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effectsEuropean Journal of Cancer and Clinical Oncology, 1984
- Megestrol acetateCancer Treatment Reviews, 1983
- Treatment of stage D prostatic carcinoma with megestrol acetateJournal of Surgical Oncology, 1981
- Megestrol acetate for treatment of advanced carcinoma of the prostateJournal of Surgical Oncology, 1975
- The use of megestrol acetate in the treatment of advanced malignant lesions of the endometriumGynecologic Oncology, 1973